Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis
暂无分享,去创建一个
[1] F. Marumo,et al. Phenotypic change in portal fibroblasts in biliary fibrosis. , 2008, Liver.
[2] R. Coffey,et al. PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[3] B. White,et al. Cytokine regulation of pulmonary fibrosis in scleroderma. , 2003, Cytokine & growth factor reviews.
[4] W. Hornebeck. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. , 2003, Pathologie-biologie.
[5] N. LaRusso,et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. , 2003, Gastroenterology.
[6] D. Brigstock,et al. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.
[7] H. Ninomiya,et al. Smad expression of hepatic stellate cells in liver cirrhosis in vivo and hepatic stellate cell line in vitro , 2003, Pathology international.
[8] M. Kasuga,et al. Histological grading and staging in chronic hepatitis: Its practical correlation , 2002, Pathology international.
[9] V. Paradis,et al. Effects and Regulation of Connective Tissue Growth Factor on Hepatic Stellate Cells , 2002, Laboratory Investigation.
[10] P. Lewindon,et al. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. , 2002, The American journal of pathology.
[11] M. Gaca,et al. Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. , 2002, Journal of hepatology.
[12] A. Baird,et al. Mast cell hyperplasia in chronic rejection after liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] Y. Nakanuma,et al. Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis. , 2001, The American journal of pathology.
[14] T. Roskams,et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.
[15] K. Tsuneyama,et al. Enhanced expression of basement‐membrane‐type heparan sulfate proteoglycan in tumor fibro‐myxoid stroma of intrahepatic cholangiocarcinoma , 2001, Pathology international.
[16] D. Schuppan,et al. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. , 2001, The American journal of pathology.
[17] K. Fang,et al. Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by α-Chymase1 , 2001, The Journal of Immunology.
[18] K. Tsuneyama,et al. Evidence of the Participation of Peribiliary Mast Cells in Regulation of the Peribiliary Vascular Plexus Along the Intrahepatic Biliary Tree , 2000, Laboratory Investigation.
[19] M. Arthur,et al. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. , 2000, Journal of hepatology.
[20] K. Tsuneyama,et al. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c‐kit‐expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis , 1999, The Journal of pathology.
[21] Gary R. Grotendorst,et al. Connective tissue growth factor mediates transforming growth factor b-induced collagen synthesis : down-regulation by cAMP , 1999 .
[22] N. Kawada,et al. In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation , 1999, Hepatology.
[23] M. Arthur,et al. Human and rat hepatic stellate cells produce stem cell factor: a possible mechanism for mast cell recruitment in liver fibrosis. , 1999, Journal of hepatology.
[24] S. Crawford,et al. Increased expression of transforming growth factor-beta1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell. , 1999, Journal of pediatric gastroenterology and nutrition.
[25] K. Toyoshima,et al. Basement membrane heparan sulfate proteoglycan (perlecan) synthesized by ACC3, adenoid cystic carcinoma cells of human salivary gland origin. , 1999, Journal of biochemistry.
[26] Gary R. Grotendorst,et al. Inhibition of TGF‐β‐stimulated CTGF gene expression and anchorage‐independent growth by cAMP identifies a CTGF‐dependent restriction point in the cell cycle , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] Y. Nakanuma,et al. Relationship between interleukin‐6 and proliferation and differentiation in cholangiocarcinoma , 1998, Histopathology.
[28] Pieter,et al. Localization and cellular sources of activins in normal and fibrotic rat liver , 1997, Hepatology.
[29] Y. Nakanuma,et al. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply , 1997, Microscopy research and technique.
[30] Gary R. Grotendorst,et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.
[31] T. Roskams,et al. Heparan sulfate proteoglycan expression in normal human liver , 1995, Hepatology.
[32] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[33] Y. Nakanuma,et al. Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey. , 1994, Human pathology.
[34] J. Hoofnagle,et al. Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.
[35] E. Wisse,et al. Tissue distribution, quantitation and proliferation kinetics of fat‐storing cells in carbon tetrachloride–injured rat liver , 1991, Hepatology.
[36] K. Austen,et al. A single gene in mast cells encodes the core peptides of heparin and chondroitin sulfate proteoglycans. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[37] K. Tsuneyama,et al. Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. , 2002, Pathology, research and practice.
[38] S. Friedman. Cytokines and Fibrogenesis , 1999, Seminars in liver disease.
[39] L. Rubbia‐Brandt,et al. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[40] W. Border,et al. Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.
[41] P. van Eyken,et al. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. , 1993, Journal of hepatology.
[42] S. Sherlock,et al. Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. , 1986, Journal of hepatology.